SE437663B - Cykloalkyltriazoler och forfarande for framstellning derav - Google Patents
Cykloalkyltriazoler och forfarande for framstellning deravInfo
- Publication number
- SE437663B SE437663B SE7903327A SE7903327A SE437663B SE 437663 B SE437663 B SE 437663B SE 7903327 A SE7903327 A SE 7903327A SE 7903327 A SE7903327 A SE 7903327A SE 437663 B SE437663 B SE 437663B
- Authority
- SE
- Sweden
- Prior art keywords
- alk
- piperazinyl
- hydrazide
- carbon atoms
- mol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT22421/78A IT1094076B (it) | 1978-04-18 | 1978-04-18 | Cicloalchiltriazoli |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7903327L SE7903327L (sv) | 1979-10-19 |
SE437663B true SE437663B (sv) | 1985-03-11 |
Family
ID=11196066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7903327A SE437663B (sv) | 1978-04-18 | 1979-04-17 | Cykloalkyltriazoler och forfarande for framstellning derav |
Country Status (22)
Country | Link |
---|---|
US (2) | US4252721A (hu) |
JP (1) | JPS5817757B2 (hu) |
AT (1) | AT374477B (hu) |
AU (1) | AU520788B2 (hu) |
BG (2) | BG40654A3 (hu) |
CA (1) | CA1104567A (hu) |
CH (1) | CH639847A5 (hu) |
DE (1) | DE2915318A1 (hu) |
DK (1) | DK148480C (hu) |
FI (1) | FI66378C (hu) |
FR (1) | FR2423221A1 (hu) |
GB (1) | GB2020269B (hu) |
HU (1) | HU179917B (hu) |
IE (1) | IE47965B1 (hu) |
IL (1) | IL56926A (hu) |
IT (1) | IT1094076B (hu) |
NL (1) | NL186635C (hu) |
PL (1) | PL116103B1 (hu) |
PT (1) | PT69502A (hu) |
SE (1) | SE437663B (hu) |
SU (1) | SU852174A3 (hu) |
YU (1) | YU41338B (hu) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399693A (en) * | 1984-04-17 | 1995-03-21 | British Technology Group Limited | Substituted piperazine-2-carboxylic acids and derivatives thereof |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2580648B1 (fr) * | 1985-04-17 | 1987-05-15 | Adir | Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant |
US4879294A (en) * | 1988-01-28 | 1989-11-07 | Angelini Pharmaceuticals Ltd. | Opthalmic composition |
IT1224250B (it) * | 1988-06-10 | 1990-09-26 | Acraf | Associzione del depiprazolo con la morfina |
IT1250701B (it) * | 1991-07-24 | 1995-04-21 | Angelini Francesco Ist Ricerca | Composizione farmaceutica solida per uso orale a base di dapiprazolo |
US5288759A (en) * | 1992-08-27 | 1994-02-22 | Alcon Laboratories, Inc. | Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis |
US6187774B1 (en) | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
KR100639543B1 (ko) | 1998-09-30 | 2006-10-31 | 다케다 야쿠힌 고교 가부시키가이샤 | 방광 배출력 개선제 |
IL141235A (en) * | 2000-02-09 | 2012-04-30 | Novartis Int Pharm Ltd | Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia |
US6730691B1 (en) | 2000-02-10 | 2004-05-04 | Miles A. Galin | Uses of alpha adrenergic blocking agents |
US20020065286A1 (en) * | 2000-08-21 | 2002-05-30 | Davies Michael John | Treatment of wounds |
US20020091129A1 (en) * | 2000-11-20 | 2002-07-11 | Mitradev Boolell | Treatment of premature ejaculation |
EP1410808A4 (en) * | 2001-07-02 | 2009-07-29 | Santen Pharmaceutical Co Ltd | MEDIUM FOR THE PROTECTION OF THE SEHNERV WITH ALPHA 1 RECEPTOR BLOCKER AS AN ACTIVE SUBSTANCE |
GB0130219D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Compounds for the treatment of sexual dysfunction |
US20030229001A1 (en) * | 2002-01-31 | 2003-12-11 | Pfizer Inc. | Treatment of male sexual dysfunction |
CN1681495B (zh) | 2002-08-19 | 2010-05-12 | 辉瑞产品公司 | 用于治疗过度增生性疾病的组合物 |
GB0219961D0 (en) | 2002-08-28 | 2002-10-02 | Pfizer Ltd | Oxytocin inhibitors |
US7323462B2 (en) * | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
PA8597401A1 (es) * | 2003-03-14 | 2005-05-24 | Pfizer | Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep |
US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
CA2526730A1 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Substituted pyrrole derivatives |
US20050065158A1 (en) * | 2003-07-16 | 2005-03-24 | Pfizer Inc. | Treatment of sexual dysfunction |
US20050037063A1 (en) * | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
US7291640B2 (en) * | 2003-09-22 | 2007-11-06 | Pfizer Inc. | Substituted triazole derivatives as oxytocin antagonists |
US20050267096A1 (en) * | 2004-05-26 | 2005-12-01 | Pfizer Inc | New indazole and indolone derivatives and their use pharmaceuticals |
US20050288270A1 (en) * | 2004-05-27 | 2005-12-29 | Pfizer Inc | New aminopyridine derivatives and their use as pharmaceuticals |
EP1863484A1 (en) * | 2005-03-21 | 2007-12-12 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
ES2313626T3 (es) * | 2005-03-21 | 2009-03-01 | Pfizer Limited | Derivados de triazol sustituidos como antagonistas de oxitocina. |
CA2618103A1 (en) * | 2005-08-10 | 2007-02-15 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
SG166829A1 (en) * | 2005-11-08 | 2010-12-29 | Ranbaxy Lab Ltd | Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
US8383660B2 (en) | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
AR059838A1 (es) * | 2006-03-14 | 2008-04-30 | Ranbaxy Lab Ltd | Formulaciones para dosis estabilizantes de estatina |
BRPI0714361A2 (pt) * | 2006-07-14 | 2013-03-26 | Ranbaxy Lab Ltd | polimorfo cristalino, composiÇço farmacÊutica contendo o mesmo, mÉtodo para sua preparaÇço e mÉtodo de tratamento |
ES2382009T3 (es) | 2006-12-01 | 2012-06-04 | Bristol-Myers Squibb Company | Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares |
JP2016516804A (ja) | 2013-04-17 | 2016-06-09 | ファイザー・インク | 心血管疾患を治療するためのn−ピペリジン−3−イルベンズアミド誘導体 |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
KR20210096096A (ko) | 2018-10-26 | 2021-08-04 | 오큐파이어 파마, 인크. | 노안, 산동, 및 기타 안구 장애의 치료를 위한 방법 및 조성물 |
EP3911648A4 (en) | 2019-01-18 | 2022-10-26 | Astrazeneca AB | PCSK9 INHIBITORS AND METHODS OF USE THEREOF |
CN115368310A (zh) | 2021-05-18 | 2022-11-22 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2913454A (en) * | 1956-11-23 | 1959-11-17 | Schenley Ind Inc | Certain cycloalkanotriazoles, process and intermediates |
IT1066857B (it) * | 1965-12-15 | 1985-03-12 | Acraf | Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione |
US3472853A (en) * | 1967-05-29 | 1969-10-14 | Sterling Drug Inc | 1-((pyrido(2,1-c)-s-triazolyl)-lower-alkyl)-4-substituted- piperazines |
JPS5070389A (hu) * | 1973-10-30 | 1975-06-11 |
-
1978
- 1978-04-18 IT IT22421/78A patent/IT1094076B/it active Protection Beyond IP Right Term
-
1979
- 1979-03-22 IL IL56926A patent/IL56926A/xx unknown
- 1979-03-22 CH CH268579A patent/CH639847A5/it not_active IP Right Cessation
- 1979-03-29 US US06/025,273 patent/US4252721A/en not_active Expired - Lifetime
- 1979-03-30 NL NLAANVRAGE7902489,A patent/NL186635C/xx not_active IP Right Cessation
- 1979-04-09 AU AU45832/79A patent/AU520788B2/en not_active Ceased
- 1979-04-11 FR FR7909229A patent/FR2423221A1/fr active Granted
- 1979-04-11 GB GB7912875A patent/GB2020269B/en not_active Expired
- 1979-04-11 YU YU862/79A patent/YU41338B/xx unknown
- 1979-04-12 FI FI791217A patent/FI66378C/fi not_active IP Right Cessation
- 1979-04-14 DE DE19792915318 patent/DE2915318A1/de active Granted
- 1979-04-17 CA CA325,782A patent/CA1104567A/en not_active Expired
- 1979-04-17 PT PT69502A patent/PT69502A/pt unknown
- 1979-04-17 HU HU79AI284A patent/HU179917B/hu unknown
- 1979-04-17 SU SU792753553A patent/SU852174A3/ru active
- 1979-04-17 SE SE7903327A patent/SE437663B/sv not_active IP Right Cessation
- 1979-04-17 DK DK156779A patent/DK148480C/da not_active IP Right Cessation
- 1979-04-18 JP JP54048519A patent/JPS5817757B2/ja not_active Expired
- 1979-04-18 AT AT0292479A patent/AT374477B/de not_active IP Right Cessation
- 1979-04-18 PL PL1979214969A patent/PL116103B1/pl unknown
- 1979-04-18 BG BG7943291A patent/BG40654A3/xx unknown
- 1979-08-08 IE IE646/79A patent/IE47965B1/en not_active IP Right Cessation
-
1980
- 1980-08-29 US US06/182,426 patent/US4307095A/en not_active Expired - Lifetime
-
1994
- 1994-02-25 BG BG98586A patent/BG61367B2/bg unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399693A (en) * | 1984-04-17 | 1995-03-21 | British Technology Group Limited | Substituted piperazine-2-carboxylic acids and derivatives thereof |
US5595983A (en) * | 1984-04-17 | 1997-01-21 | British Technology Group Limited | Substituted piperazine 2-carboxylic acids useful in the treatment of central nervous system disorders |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE437663B (sv) | Cykloalkyltriazoler och forfarande for framstellning derav | |
NZ236105A (en) | 6h-dipyrido[3,2-b:2',3'-e][1,4] diazapin-6-one (and thione) derivative, preparation and pharmaceutical compositions thereof | |
EP0125607A2 (en) | Pyrido(1,5)benzodiazepinone derivatives and pharmacological activities thereof | |
US3399201A (en) | Aminoalkyl-ethano-anthracenes | |
US3594380A (en) | Isoquinolin-1(2h)-ones | |
EP0463810B1 (en) | Heterocyclic compound and psychopharmaceutical composition containing same | |
HUT65947A (en) | Imidazo-pyridine - derivatives with paf/h1 antagonist activity and pharmaceutical compositions containing them and process for the production thereof | |
KR930007413B1 (ko) | 새로운 피리딜- 및 피리미딜 유도체와 약리학적으로 활성인 그의 염 및 그 제조방법과 이들을 이용한 사람 이외의 온혈동물의 정신장해 치료방법 | |
CS259516B2 (en) | Method of new heterocyclic compounds production | |
SK3632003A3 (en) | Benzodiazepine derivatives, pharmaceutical composition comprising same and their use | |
US3177211A (en) | 10-[(aminocarbamyl-1-piperidyl)-loweralkyl]-phenothiazines | |
JPS6335573A (ja) | 新規置換ピリド〔2,3−b〕〔1,4〕ベンゾジアゼピン−6−オン,その製法及びその化合物を含む医薬 | |
HU194228B (en) | Process for production of new, in 11-position substituated 5,11-dihydro-6h-pirido /2,3-b//1,4/-benzodiozepin-6-on and medical compounds containing thereof | |
US4325952A (en) | Method of treating abstinence syndrome with cycloaklyltriazoles | |
NZ247637A (en) | Thiochroman derivatives and pharmaceutical compositions | |
JP3117183B2 (ja) | 5,6−ジヒドロ−4H−イミダゾ〔4,5,1−ij〕キノリン類、その製造方法、それを含む鎮痛剤および中間体化合物 | |
CA1267894A (en) | 4-substituted 10-cyanomethylenethieno[4,3-e] benzoazepines | |
JPH0764844B2 (ja) | ピリダジノピロロイソキノリン誘導体 | |
KR820001450B1 (ko) | 사이클로알킬 트리아졸의 제조방법 | |
CS207624B2 (en) | Method of making the substituted lactanes of the hexahydro-benzopyrano-3,2-c pyridin vinegar acids | |
US4307096A (en) | Method of treating glaucoma with cycloalkyltriazoles | |
JPS624288A (ja) | 新規なジアゼピノン化合物 | |
KR20010014144A (ko) | 빈뇨·요실금 치료·예방제 및 트로폰 유도체 | |
JPH03294277A (ja) | ピペリジン誘導体 | |
KR890001195B1 (ko) | 융합된 방향족 티아제피논 및 이의 황동족체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7903327-0 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7903327-0 Format of ref document f/p: F |